[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:dyslipidemia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":207,"states":208},"Dyslipidemia",32,21,[8,16,22,29,35,41,47,54,60,66,72,79,85,91,96,102,108,114,120,126,132,138,144,150,156,163,169,175,182,188,194,200],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06496243","Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels",[12],"Phase 2","RECRUITING","2026-08-26T02:16:54.044282Z","2026-05-05T02:43:29.478056Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06300450","Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy",[],"2026-08-26T02:17:30.145302Z","2026-05-05T02:43:28.205971Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06980428","A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia",[26],"Phase 1","2026-08-26T02:15:59.318403Z","2026-05-05T02:43:29.671201Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06526273","PILI 'Āina Household",[],"2026-08-26T02:16:55.892527Z","2026-05-05T02:43:29.385996Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05488431","Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",[12],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.714261Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06526650","'Ai Pono Cooking Demonstrations",[],"2026-08-26T02:17:19.710918Z","2026-05-05T02:43:27.638104Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT07667803","A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM",[51],"Phase 3","2026-08-26T02:17:15.156099Z","2026-07-05T03:45:20.369840Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07491172","A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias",[26],"2026-08-26T02:18:15.214990Z","2026-05-05T02:43:29.073051Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT07119658","Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial",[],"2026-08-03T03:24:20.303158Z","2026-05-05T02:43:27.760987Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07246408","Intermittent Cottonseed Oil Consumption",[],"2026-08-26T02:17:22.153941Z","2026-05-05T02:43:29.538146Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":77,"content_modified":78},"NCT05700916","Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity",[76],"Early Phase 1","2026-08-03T02:18:34.888562Z","2026-05-05T02:43:26.902213Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT06382298","Cottonseed Oil Versus Matched PUFA Effects",[],"2026-08-26T02:19:14.560989Z","2026-04-29T02:57:57.140604Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT07221279","Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight\u002FObese Adults",[],"2026-08-26T02:17:35.666428Z","2026-05-05T02:43:29.363503Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":52,"content_modified":95},"NCT06676046","Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions",[],"2026-05-13T02:55:06.561364Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT05129345","Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US",[],"2026-08-26T02:18:16.220328Z","2026-05-13T02:55:06.285360Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT05000996","Gut Microbiota in Metabolic Surgery",[],"2026-08-26T02:18:26.129155Z","2026-05-13T02:55:06.276727Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT00353782","Causes and Natural History of Dyslipidemias",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.034953Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT02024542","Metabolic Responses to Bariatric Surgery",[],"2026-08-26T02:18:38.077159Z","2026-05-13T02:55:06.080702Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT07238556","A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors",[],"2026-08-26T02:15:58.452248Z","2026-05-05T02:43:29.169367Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT06587204","Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health",[],"2026-08-26T02:16:48.735701Z","2026-05-05T02:43:26.896831Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT06439654","Atlantic Lipid Lowering Treatment Optimization Program",[],"2026-08-26T02:19:29.119921Z","2026-05-05T02:43:26.681995Z",{"nct_id":139,"title":140,"phases":141,"status":142,"updated_at":33,"content_modified":143},"NCT07654231","Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD",[12],"NOT_YET_RECRUITING","2026-07-05T05:32:16.643674Z",{"nct_id":145,"title":146,"phases":147,"status":142,"updated_at":148,"content_modified":149},"NCT07545005","Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth",[],"2026-08-26T02:19:19.975067Z","2026-05-05T02:43:29.387670Z",{"nct_id":151,"title":152,"phases":153,"status":142,"updated_at":154,"content_modified":155},"NCT07696403","Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose",[],"2026-08-26T02:18:05.435729Z","2026-07-19T19:36:05.175753Z",{"nct_id":157,"title":158,"phases":159,"status":142,"updated_at":161,"content_modified":162},"NCT07732400","A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)",[160],"Phase 1\u002FPhase 2","2026-08-26T02:15:01.639696Z","2026-07-30T01:46:14.453148Z",{"nct_id":164,"title":165,"phases":166,"status":142,"updated_at":167,"content_modified":168},"NCT06590649","Household Participants",[],"2026-08-26T02:17:45.190188Z","2026-05-05T02:43:29.409798Z",{"nct_id":170,"title":171,"phases":172,"status":142,"updated_at":173,"content_modified":174},"NCT07340580","Implementation Facilitation of Exercise is Medicine Greenville",[],"2026-08-26T02:18:35.425468Z","2026-05-05T02:43:27.975601Z",{"nct_id":176,"title":177,"phases":178,"status":179,"updated_at":180,"content_modified":181},"NCT07387393","To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:13.549512Z","2026-05-05T02:43:27.514601Z",{"nct_id":183,"title":184,"phases":185,"status":179,"updated_at":186,"content_modified":187},"NCT06369571","Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet",[160],"2026-08-26T02:19:31.671303Z","2026-06-16T05:54:07.748855Z",{"nct_id":189,"title":190,"phases":191,"status":179,"updated_at":192,"content_modified":193},"NCT07094412","Patient-engaged Development and Testing of Educational Content on Side Effects of Statins",[],"2026-08-26T02:18:58.958025Z","2026-06-16T05:54:07.854164Z",{"nct_id":195,"title":196,"phases":197,"status":179,"updated_at":198,"content_modified":199},"NCT06989281","Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB",[],"2026-08-26T02:15:46.655893Z","2026-06-16T05:54:07.845084Z",{"nct_id":201,"title":202,"phases":203,"status":204,"updated_at":205,"content_modified":206},"NCT06296251","Dietary Supplementation on Body Fat Composition",[],"UNKNOWN","2026-08-03T01:58:01.892442Z","2026-05-05T02:43:26.691760Z",[],[209,213,216,219,223,226,229,233,236],{"state":210,"count":211,"slug":212},"Florida",5,"florida",{"state":214,"count":211,"slug":215},"Georgia","georgia",{"state":217,"count":211,"slug":218},"Maryland","maryland",{"state":220,"count":221,"slug":222},"California",4,"california",{"state":224,"count":221,"slug":225},"Hawaii","hawaii",{"state":227,"count":221,"slug":228},"Texas","texas",{"state":230,"count":231,"slug":232},"Connecticut",3,"connecticut",{"state":234,"count":231,"slug":235},"New York","new-york",{"state":237,"count":231,"slug":238},"North Carolina","north-carolina"]